Authors
Loading...
Comprehensive analysis highlights regulatory impact on phase III trial quality in India from 2007 to 2025.
Sahoo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: